Loading...
Loading...
NEW YORK, NY · CIK 0001263508
New positions
5
Added to
9
Trimmed
11
Exited
9
BAKER BROS. ADVISORS LP (NEW YORK, NY) reported a portfolio value of $21.04B across 80 positions in their Q3 2026 SEC 13F filing (period ending 2026-09-30). The top 10 positions account for 77.2% of the portfolio.
Top 30 holdings by portfolio weight. Block width = holding percentage. Green = new/increased, red = reduced, gray = unchanged.
| # | Stock | Value↓ | Weight | Change |
|---|---|---|---|---|
| 1 | INCYIncyte Corporation | $3.73B | 17.74% | +0.0% |
| 2 | ONCBeOne Medicines Ltd. | $3.23B | 15.36% | +0.3% |
| 3 | RVMDRevolution Medicines, Inc. | $2.18B | 10.38% | -7.0% |
| 4 | KODKodiak Sciences Inc. | $2.07B | 9.85% | +9.7% |
| 5 | MDGLMadrigal Pharmaceuticals, Inc. | $1.08B | 5.13% | - |
| 6 | INSMInsmed Incorporated | $1.00B | 4.77% | - |
| 7 | KYMRKymera Therapeutics, Inc. | $967.79M | 4.60% | - |
| 8 | ACADACADIA Pharmaceuticals Inc. | $864.70M | 4.11% | - |
| 9 | GRALGRAIL, Inc. | $564.49M | 2.68% | - |
| 10 | SMMTSummit Therapeutics Inc. | $554.42M | 2.63% | - |
| Stock | Value | Shares |
|---|---|---|
| TRAXFirst Tracks Biotherapeutics, Inc. | $16.76M | 472,932 |
| SCTXScribe Therapeutics Inc. | $12.68M | 688,691 |
| FRNMFreenome, Inc. | $12.52M | 794,908 |
| QTTBQ32 Bio Inc. | $4.53M | 547,945 |
| SKYESkye Bioscience, Inc. | $317.02K | 196,905 |
One weekly email with notable insider buys, sells and congressional disclosures. Unsubscribe anytime.